Analysis of Human DNA in Stool Samples as
a Technique for Colorectal Cancer Screening
Analysis
of Proteomic Patterns in Serum to Identify Ovarian Cancer
Apolipoprotein
B Testing for Screening, Diagnosis and Management of Dyslipidemia and
Cardiovascular Disease
Apolipoprotein
E Testing for Screening, Diagnosis and Management of Dyslipidemia and
Cardiovascular Disease
Breast Cancer
Tumor Markers
Cancer Screening
of the Cervix
Collagen
Cross Links as Markers of Bone Turnover
Cytochrome
p450 Genotyping
Cytologic
Evaluation in Breast Cancer Risk Assessment
Detection
and Quantification of Circulating Tumor Cells in the Management of Individuals
with Cancer
Diagnostic Labwork for Erectile Dysfunction
Epidermal
Growth Factor Receptor (EGFR) Mutation Analysis for Individuals with Non-Small
Cell Lung Cancer (NSCLC)
Fetal Fibronectin (fFN) to Predict Preterm Labor
Gastrointestinal
Cancer Tumor Markers
Gene
Expression Profiling Assays as a Technique to Determine Prognosis for
Managing Breast Cancer Treatment
Gene-based
Tests for Screening, Detection, and/or Management of Prostate Cancer
Genetic
Testing for Alzheimer's Disease
Genetic
Testing for BRCA1 or BRCA2 for Breast or Ovarian Cancer
Genetic
Testing for Congenital Cardiac Channelopathies
Genetic
Testing for Cutaneous Malignant Melanoma
Genetic
Testing for Cystic Fibrosis
Genetic
Testing for Helicobacter pylori Treatment
Genetic Testing for HER-2
Genetic
Testing for Inherited Susceptibility to Colorectal Cancer
Genetic
Testing for Medullary Thyroid Carcinoma
Genetic
Testing for Tamoxifen Treatment
Genetic
Testing for Tay-Sach's Disease
Genetic
Testing for Warfarin Dose
Genotyping
for Chronic Hepatitis C
High-Density
Lipoprotein (HDL) Subclass Testing for Screening, Diagnosis and Management
of Dyslipidemia and Cardiovascular Disease
High
Sensitivity C-Reactive Protein (hs-CRP) Testing for Cardiovascular Disease
(CVD)
Homocysteine
Testing in the Screening, Diagnosis, and Management of Dyslipidemia and
Cardiovascular Disease
Immunochemical
Fecal Occult Blood Tests
In
Vitro Chemosensitivity and Chemoresistance Assays
In
Vitro Particle Size Measurement for Screening Hypersensitivity Reactions
to Foods and Chemicals
Laboratory
Tests for Heart Transplant Rejection
Leukocyte Histamine Release Test (LHRT)
Lipoprotein(a)
Enzyme Immunoassay in the Management of Cardiovascular Disease
Low-Density
Lipoprotein (LDL) Subclass Testing for Screening, Diagnosis and Management
of Dyslipidemia and Cardiovascular Disease
Lymphocytic
Mitogen Response Assay for the Diagnosis of Vitamin, Mineral, and Antioxidant
Functional Deficiencies
Measurement
of Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) in the Assessment
of Cardiovascular Risk
Measurement
of Serum Intermediate Density Lipoproteins (Remnant Lipoproteins)
Microalbumin Screening
for Diabetic Nephropathy
Microarray-based
Gene Expression Testing for Cancers of Unknown Primary
Nuchal Translucency
with or without Maternal Serum PAPP-A and Free ß-hCG Levels as a First-Trimester
Screening for Down Syndrome (Trisomy 21) and Edward Syndrome (Trisomy
18)
Ovarian
Cancer Tumor Markers
Prostate Specific Antigen (PSA)
Saliva Testing for Hormone
Levels
Salivary Estriol Testing
Sentinel Node Biopsy
for the Staging of Breast Cancer and Malignant Melanoma
Serum
Antibodies for the Diagnosis and Management of Inflammatory Bowel Disease:
ANCA for Ulcerative Colitis and ASCA for Crohn's Disease
Specific IgE In Vitro Tests (RAST, MAST & FAST)
Total Serum IgE Concentration
Urine-Based
HIV-1 Testing System